Immediate Impact
4 by Nobel laureates 2 from Science/Nature 53 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
2025 Standout
Works of Frank Tsai being referenced
Phase I study of the arginase inhibitor INCB001158 (1158) alone and in combination with pembrolizumab (PEM) in patients (Pts) with advanced/metastatic (adv/met) solid tumours
2019
Abstract CT112: Durvalumab + tremelimumab in patients with metastatic urothelial cancer
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Frank Tsai | 272 | 95 | 172 | 148 | 36 | 459 | |
| Jii Bum Lee | 306 | 127 | 180 | 164 | 46 | 507 | |
| Robert Aiken | 189 | 71 | 217 | 114 | 36 | 551 | |
| Saif Zaman | 337 | 43 | 169 | 175 | 38 | 496 | |
| Rosemarie Krupar | 305 | 114 | 215 | 152 | 31 | 538 | |
| Houssein Abdul Sater | 365 | 81 | 119 | 288 | 33 | 494 | |
| Antonio Cusmai | 280 | 118 | 191 | 136 | 28 | 558 | |
| Yelena Novik | 306 | 145 | 126 | 196 | 44 | 518 | |
| Andrew Cannon | 239 | 49 | 244 | 128 | 23 | 482 | |
| David C. Qian | 188 | 88 | 104 | 164 | 40 | 450 | |
| D Oberberg | 183 | 43 | 145 | 156 | 22 | 493 |
All Works
Login with ORCID to disown or claim papers
Loading papers...